Form 4: Rocket Pharmaceuticals Executive Sells Shares to Cover Tax Obligations

John Militello, a Vice President at Rocket Pharmaceuticals, sold 896 shares of common stock on January 23, 2025, to cover tax obligations related to vesting Restricted Stock Units.

Summary

• On January 23, 2025, John Militello, Vice President of Finance, Treasurer, and Principal Accounting Officer at Rocket Pharmaceuticals, sold 896 shares of common stock.
• The sale was executed at a price of $10.38 per share.
• This transaction was conducted to cover tax withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
• Following the transaction, Militello directly owns 48,414 shares of Rocket Pharmaceuticals common stock.

Sentiment

Score: 5

Explanation: The document is a standard regulatory filing detailing a stock sale by an executive to cover tax obligations. It doesn't inherently indicate positive or negative sentiment.

Industry Context

Form 4 filings are a routine part of the US stock market, providing transparency into the transactions of company insiders. This filing indicates that a company executive sold shares, which is a common occurrence for covering tax obligations related to equity compensation.

Stakeholder Impact

• The sale of shares by an executive could have a minor impact on shareholder sentiment, but is unlikely to be significant given the reason for the sale.

Key Dates